American Journal of Bioethics

The *American Journal of Bioethics* (AJOB), abbreviated as *Am J Bioethics* (ISSN: 1526-5161), stands as the preeminent peer-reviewed journal in the field of bioethics, distinguished by its exceptional 2026 Impact Factor of 17.600 and its consistent placement in the Q1 quartile of the JCR. Published by Taylor & Francis, the journal serves as the leading forum for rigorous, interdisciplinary analysis of ethical issues arising in clinical medicine, biomedical research, health policy, and public health. Its scope encompasses the full spectrum of bioethical inquiry, including but not limited to genetic technologies, reproductive ethics, end-of-life care, research integrity, health justice, organ transplantation, and the ethical implications of emerging biotechnologies such as artificial intelligence and gene editing. AJOB publishes a variety of article types, with its signature feature being the target article and open peer commentary format, which fosters robust, real-time scholarly debate. In addition to these major articles, the journal features original research articles, systematic reviews, case studies, and book reviews. The primary target audience includes bioethicists, physicians, nurses, healthcare administrators, legal scholars, philosophers, and policymakers engaged in ethically complex decisions. Notably, AJOB offers an open access option for authors, ensuring broad dissemination of its influential content. Its unparalleled impact factor and top-tier quartile ranking underscore its standing as the highest-impact journal in its discipline, making it an essential resource for shaping both academic discourse and practical ethical standards in healthcare and the life sciences worldwide.